Organogenesis Holdings (ORGO) Change in Receivables (2016 - 2026)

Organogenesis Holdings' Change in Receivables history runs 11 years deep, the most recent figure standing at -$104.5 million for Q1 2026.

• On a quarterly basis, Change in Receivables fell 1743.72% year-over-year to -$104.5 million in Q1 2026; TTM through Mar 2026 was $17.0 million, a 54.05% increase from a year earlier, with the FY2025 full-year figure at $115.8 million, up 264.16% from the prior year.
• Change in Receivables slipped to -$104.5 million in Q1 2026 per ORGO's latest filing, from $51.5 million in the prior quarter.
• Across five years, Change in Receivables topped out at $51.5 million in Q4 2025 and bottomed at -$104.5 million in Q1 2026.
• The 5-year median for Change in Receivables is $3.4 million (2023), against an average of $2.7 million.
• Across the five-year window, Change in Receivables surged 1799.8% in 2025 and tumbled 1743.72% in 2026, its largest moves.
• Year by year, Change in Receivables stood at -$2.7 million in 2022, then sank by 166.42% to -$7.3 million in 2023, then surged by 220.6% to $8.8 million in 2024, then surged by 484.71% to $51.5 million in 2025, then plunged by 303.0% to -$104.5 million in 2026.
• Per Business Quant, the three latest ORGO Change in Receivables figures stand at -$104.5 million (Q1 2026), $51.5 million (Q4 2025), and $50.7 million (Q3 2025).